作者：
Nan,Zhang [1]
;
Radojka M,Savic [1]
;
Martin J,Boeree [2]
;
Charles A,Peloquin [3]
;
Marc,Weiner [4]
;
Norbert,Heinrich [5]
;
Erin,Bliven-Sizemore [6]
;
Patrick P J,Phillips [7]
;
Michael,Hoelscher [5]
;
William,Whitworth [6]
;
Glenn,Morlock [6]
;
James,Posey [6]
;
Jason E,Stout [8]
;
William,Mac Kenzie [6]
;
Robert,Aarnoutse [2]
;
Kelly E,Dooley [9]
;
Tuberculosis Trials Consortium (TBTC) and Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) Networks
作者单位：
University of California, San Francisco, School of Pharmacy, San Francisco, CA, USA.
[1]
Depts of Lung Diseases and Pharmacy, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.
[2]
College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
[3]
Veterans Administration Medical Center, San Antonio, TX, USA.
[4]
Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, and German Center for Infection Research (DZIF), Munich Partner site, Munich, Germany.
[5]
Centers for Disease Control and Prevention, Atlanta, GA, USA.
[6]
Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
[7]
UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
[8]
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
[9]
DOI
10.1183/13993003.02013-2020
PMID
33542052
发布时间
2022-07-21
换一批
换一批
